Feb. 20, 2009
The Dx-pH Measurement System from Respiratory Technology Corp., San Diego, has received CE Mark approval, allowing introduction to the European Union and all countries recognizing the CE Mark. This approval certifies Restech has met E.U. health, safety, and environmental requirements that ensure consumer safety.
Restech's Dx-System provides valuable information about patients' pharyngeal acid exposure and its role in various comorbidities, helping physicians diagnose the cause of the patient's symptoms more accurately, and treat the patient more effectively.
"The CE Mark approval is a result of our efforts and desire to bring this much needed technology to physicians worldwide," said Leo R. Roucher, chief executive officer of Restech. "In response to requests from the international community, we can now provide the technology to help diagnose and treat patients more quickly, comfortably, and effectively."